Brief: Anika Therapeutics Q3 Revenue USD 41.465 Million
02/11/2023 20:05
Nov 02 (Reuters) - Anika Therapeutics Q3 gross profit USD 24.944 million. * Q3 income from operations USD -7.674 million * Q3 net income USD -6.576 million * Q3 pretax profit USD -7.039 million
Recent news on Anika Therapeutics
See all newsAnika Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Anika Therapeutics Q2 revenue rises, lifts 2026 outlook
Anika Therapeutics Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Anika Therapeutics Enters Fifth Amendment To Credit Agreement - SEC Filing
Anika Therapeutics Q1 revenue rises 13%